Privia Health Group, Inc.
NASDAQ:PRVAMedical - Healthcare Information Services
+$0.15 today
- Market cap
- $3.14B
- Beta
- 0.87
- P/E (TTM)
- 134.4
- EPS (TTM)
- $0.18
Volume 2.38M
Average 0.95M
PRVA Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Privia Health Group, Inc.NASDAQ: PRVA
Common Stock · Q2 FY2026 · quarter ended Jun 2026
Common stock rises 2.9% from a year ago
Common stock stood at $1.26M at the end of Q2 FY2026, up 2.9% from a year earlier and up 0.5% from the prior quarter. Over 3 fiscal years it compounded at +2.5% a year.
Context
- Common stock amounted to 0.1% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
- Common stock increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether common stock keeps rising in the next quarterly balance sheet after a +2.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2025
- 1.24M USD
- Year-over-year change
- +2.7%
- 4-year CAGR
- +3.5%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.24M | +2.7% |
| FY2024 | 2024-12-31 | 1.2M | +1.8% |
| FY2023 | 2023-12-31 | 1.18M | +3.0% |
| FY2022 | 2022-12-31 | 1.15M | +6.5% |
| FY2021 | 2021-12-31 | 1.08M | — |
Common Stock vs competitors
How PRVA compares with its peers on the latest reported figures
- PRVA's Jun 2026 common stock of $1.26M is the 2nd highest of the 10 companies compared; the peer median is $167K.
- Its year-over-year change of +2.9% is the 4th highest of 10, against a peer median of +1.6%.
- Common stock amounts to 0.1% of total assets for PRVA, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $1.61B | +1.6% | +4.1% | 391.3% | |
| Jun 2026 | $1.26M | +2.9% | +2.5% | 0.1% | |
| Mar 2026 | $1.19M | +0.9% | +5.0% | 0.1% | |
| Apr 2026 | $632K | +3.9% | +4.6% | 0.1% | |
| Mar 2026 | $180K | +2.9% | +3.0% | 0.0% | |
| Mar 2026 | $167K | +5.7% | -60.9% | 0.1% | |
| Mar 2026 | $166K | -96.0% | +0.2% | 0.0% | |
| Mar 2026 | $59K | +637.5% | +40.3% | 0.0% | |
| Mar 2026 | $49K | +0.0% | +1.4% | 0.0% | |
| Mar 2026 | $43K | +0.0% | +39.0% | 0.0% | |
| Peer median (excluding PRVA) | $167K | +1.6% | +4.1% | 0.0% | |
Competitors are the stored peer set for PRVA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 320.58M | 347.99M | 389.51M | 491.15M | 479.69M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 117.4M | 189.6M | 290.77M | 316.18M | 400.9M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 14.37M | 20.53M | 27.5M | 30.41M |
| Total Current Assets | 446.68M | 551.96M | 700.8M | 834.82M | 911M |
| Property, Plant & Equipment (Net) | 14.14M | 11.48M | 8.94M | 6.07M | 9.3M |
| Goodwill | 127.94M | 126.94M | 138.75M | 141.62M | 209.84M |
| Intangible Assets | 59.74M | 57.39M | 107.63M | 109.81M | 215.92M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 33.36M | 40.37M | 35.2M | 26.38M | 2.27M |
| Other Non-current Assets | 4.52M | 4.68M | 8.58M | 17.09M | 21.04M |
| Total Non-current Assets | 239.7M | 240.85M | 299.1M | 300.96M | 458.38M |
| Total Assets | 686.37M | 792.81M | 999.9M | 1.14B | 1.37B |
| Account Payables | 2.97M | 6.73M | 7.88M | 9.76M | 7.97M |
| Short-term Debt | 875K | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 148.2M | 214.6M | 332.05M | 370.61M | 503.07M |
| Total Current Liabilities | 190.46M | 264.27M | 386.95M | 449.15M | 568.52M |
| Long-term Debt | 31.69M | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 3M | 1M | 313K | 153K | 2.58M |
| Total Non-current Liabilities | 45.73M | 9.49M | 5.56M | 3.19M | 9.92M |
| Total Liabilities | 236.19M | 273.76M | 392.51M | 452.34M | 578.44M |
| Common Stock | 1.08M | 1.15M | 1.18M | 1.2M | 1.24M |
| Retained Earnings | (208.11M) | (216.69M) | (193.61M) | (179.23M) | (156.31M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 23.31M | 19.96M | 45.95M | 48.26M | 53.73M |
| Total Equity | 450.18M | 519.05M | 607.39M | 683.45M | 790.94M |
| Total Debt | 46.5M | 11.5M | 8.29M | 5.59M | 9.53M |
| Net Debt | (274.08M) | (336.49M) | (381.22M) | (485.56M) | (470.15M) |
Privia Health Group, Inc.
NASDAQ:PRVA
Intrinsic Alpha fair value
Locked
Current Price
$24.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.